Health care stocks skyrocket in response to a likely GOP Senate

Andrew Trunsky, DCNF

Health care stocks soared Wednesday after Republicans seemed likely to hold their Senate majority in a potentially divided government, preliminary election results showed.

With a GOP Senate, many sought after policy goals from either party, ranging from drug price legislation to Medicare-for-All, are highly unlikely to come to fruition, and instead will ensure what has become a profitable status quo, Axios reported.

While some companies saw shares rise approximately 6%, others, like Cigna and Anthem, rose over 15%, according to Axios.

The health care stock bump mirrors a similar surge in 2018 when Democrats took the House of Representatives, according to the outlet.

In a note to investors Wednesday, Spencer Perlman, an analyst at the health care policy firm Veda Partners, wrote that the likely election results means that “the public option and direct government negotiation on drug prices are dead for at least the next two years.

Perhaps more important is that divided government all but guarantees the short-term preservation of employer health coverage, which has been extraordinary profitable for health care companies.

Though the initial results have been promising for the industry, it faces another possible hurdle next week. The Supreme Court is set to hear a case Tuesday that Democrats say could potentially invalidate the Affordable Care Act, which could cause significant disruption for companies that have spent the last decade structuring their policies around the law.

If the ACA is overturned, the number of uninsured Americans would skyrocket, potentially leading to more uncompensated care from hospitals as a result, according to Axios.

Though Republicans are likely to hold Congress’s upper chamber, Democrats’ hopes are not completely destroyed. Four senate races have yet to be called, and if Democrats win three then they would have a 51-seat majority, though forecasters indicate that is unlikely.

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of our original content, please contact [email protected].

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

BPR INSIDER COMMENTS

Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!

Latest Articles